Luca Pasquini
Assistant Professor of Radiology and Biomedical Imaging; Director of Functional Neuroimaging
Data updated
Research Footprint
Luca Pasquini appears in 6 tracked papers (2020–2026), most studied alongside Psilocybin, DMT and Ayahuasca, across Healthy Volunteers, Neuroimaging & Brain Measures and Depressive Disorders.
Most-cited paper: Subacute Effects of the Psychedelic Ayahuasca on the Salience and Default Mode Networks (99 citations).
Frequent co-authors: Robin Carhart-Harris, Leor Roseman and Adam Gazzaley.
Background & Research
Dr. Luca Pasquini is an MD/PhD physician-scientist at Yale School of Medicine. He graduated in medicine from the University of Florence, completed radiology residency and a PhD in neuroplasticity at La Sapienza University of Rome, and later trained in neuro-oncology imaging and nuclear medicine at Memorial Sloan Kettering Cancer Center. His research focuses on neuroimaging, brain connectivity, artificial intelligence, and molecular imaging.
Key Impact
He is a Yale physician-scientist publishing on functional neuroimaging and brain connectivity, including multiple psychedelic-neuroscience papers.
Collaboration Network
26 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Luca Pasquini's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Luca Pasquini is associated with.